Home » Topics » Regulatory

Regulatory
RSS

Eligard 7.5 mg launched for advanced prostate cancer

May 29, 2002

MicardisPlus approved in E.U. for hypertension

May 28, 2002

New indication and low dose strength of Vivelle-Dot approved

May 27, 2002

Copaxone prefilled syringes launched in Canada

May 27, 2002

MitoExtra NDA amendment accepted for filing

May 27, 2002

New strengths of Adderall XR approved for ADHD

May 27, 2002

Zelapar NDA in Parkinson's disease accepted for filing

May 27, 2002

Remodulin approved for pulmonary arterial hypertension

May 24, 2002

FDA advisory committee supports efficacy of Prevnar in otitis media

May 23, 2002

Low-dose formulation of Retin-A Micro approved by FDA

May 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...